Nevrološka prizadetost kot dejavnik kakovosti življenja starejših pacientov z multiplo sklerozo
presečna raziskava
DOI:
https://doi.org/10.14528/snr.2021.55.1.3058Ključne besede:
telesno zdravje, duševno zdravje, staranjePovzetek
Uvod: Kakovost življenja predstavlja pomembno dimenzijo življenja pacientov z multiplo sklerozo, na katero vplivajo številni dejavniki. Namen raziskave je ugotoviti vpliv nevrološke prizadetosti na telesno in duševno z zdravjem povezano kakovost življenja pacientov z multiplo sklerozo, starih med 50 in 59 let ter starejših od 60 let.
Metode: Presečna raziskava je bila izvedena na vzorcu 130 pacientov z multiplo sklerozo, starih med 50 in 73 let. Ocenjeni so bili z razširjeno lestvico stopnje nevrološke prizadetosti, vprašalnikom o kakovosti življenja pri multipli sklerozi (telesna in duševna z zdravjem povezana kakovost življenja) in vprašalnikom o značilnostih pacientov z multiplo sklerozo. Uporabljeni so bili opisna statistika, Kolmogorov-Smirnov test, Spearmanov koeficient korelacije rangov in linearna regresijska analiza.
Rezultati: Nevrološka prizadetost pri pacientih z multiplo sklerozo, starih med 50 in 59 let, vpliva na telesno z zdravjem povezano kakovost življenja (R² = 0,251, p < 0,001), pri pacientih, starih med 60 in 73 let, pa na telesno (R² = 0,250, p < 0,001) in duševno z zdravjem povezano kakovost življenja (R² = 0,063, p = 0,044).
Diskusija in zaključek: Vpliv nevrološke prizadetosti se po 60. letu starosti s telesne razširi tudi na duševno raven življenja pacientov z multiplo sklerozo. Nevrološko prizadeti pacienti morajo biti z namenom ohranjanja kakovosti življenja med 50. in 59. letom spremljani na področju fizičnega zdravja, med 60. in 73. letom pa tudi na področju duševnega zdravja.
Prenosi
Metrike
Literatura
Baumstarck-Barrau, K., Simeoni, M. C., Reuter, F., Klemina, I., Aghababian, V., Pelletier, J., & Auquier, P. (2011). Cognitive function and quality of life in multiple sclerosis patients: A cross-sectional study. BMC Neurology, 11(17), 1–10. https://doi.org/10.1186/1471-2377-11-17 PMid:21288343; PMCid:PMC3039581
Benedict, R. H. B, Wahlig, E., Bakshi, R., Fishman, I., Munschauer, F., Zivadinov, R., & Weinstock-Gutmann, B. (2005). Predicting quality of life in multiple sclerosis: Accounting for physical disability, fatigue, cognition, mood disorder, personality, and behavior change. Journal of the Neurological Sciences, 231(1/2), 29–34. https://doi.org/10.1016/j.jns.2004.12.009 PMid:15792817
Berrigan, L. I., Fisk, J. D., Patten, S. B., Tremlett, H., Wolfson, C., Warren, S. ... Marrie R. A. (2016). Health-related quality of life in multiple sclerosis: Direct and indirect effects of comorbidity. Neurology, 86(15), 1417–1424. https://doi.org/10.1212/WNL.0000000000002564 PMid:26962068; PMCid:PMC4831037
Brola, W., Sobolewski, P., Fudala, M., Flaga, S., Jantarski, K., Ryglewicz, D., & Potemkowski A. (2016). Self-reported quality of life in multiple sclerosis patients: Preliminary results based on the Polish MS Registry. Patient Preference and Adherence, 10, 1647–1656. https://doi.org/10.2147/PPA.S109520 PMid:27616882; MCid:PMC5008638
Buhse, M., Banker, W. M., & Clement, L. M., (2014). Factors Associated with health-related quality of life among older people with multiple sclerosis. International Journal of MS Care, 16(1), 10–19. https://doi.org/10.7224/1537-2073.2012-046 PMid:24688350; PMCid:PMC3967699
Caprio, M. G., Russo, C., Giugliano, A., Ragucci, M., & Mancini, M. (2016). Vascular disease in patients with multiple sclerosis: A review. Journal of Vascular Medicine & Surgery, 4(259), 1–12. https://doi.org/10.4172/2329-6925.1000259
Çelik Gökçen Gözübatık, R. (2018). Upper extremity capability tests in multiple sclerosis. Archives of Neuropsychiatry, 55(Suppl 1), 54–57. https://doi.org/10.29399/npa.23338 PMCid:PMC6278626; PMid:30692857
Chen, K., Fan, Y., Hu, R., Yang, T., & Li, K. (2013). Impact of depression, fatique and disability on quality of life in Chinese patients with multiple sclerosis. Stress and Health, 29(2), 108–112. https://doi.org/10.1002/smi.2432 PMid:22566371
European Multiple Sclerosis Platform. (2012). Recommendations on rehabilitation services for persons with multiple sclerosis in Europe. Brussels: European Multiple Sclerosis Platform. Retrieved October 25, 2019 from https://www.eurims.org/News/recommendations-on-rehabilitation-services-forpersons-with-multiple-sclerosis-in-europe.html
Finlayson, M. (2009). Multiple sclerosis and ageing: Complexities, concerns and considerations for care. Aging Health, 5(1), 89–102. https://doi.org/10.2217/1745509X.5.1.89
Fong, T., Finlayson, M., & Peacock, N. (2006). The social experience of aging with a chronic illness: Perspectives of older adults with multiple sclerosis. Disability and Rehabilitation, 28(11), 695–705. https://doi.org/10.1080/09638280500277495 PMid:16809212
Jongen, P. J. (2017). Health-related quality of life in patients with multiple sclerosis: Impact of disease-modifying drugs. CNS Drugs, 31(7), 585–602. https://doi.org/10.1007/s40263-017-0444-x PMid:28608280; PMCid:PMC5511298
Karabudak, R., Dahdaleh, M., Aljumah, M., Alroughani, R., Alsharoqi, I. A., AlTahan, A. M. … Yamout, B. I. (2015). Functional clinical outcomes in multiple sclerosis: Current status and future prospects. Multiple Sclerosis and Related Disorders, 4(3), 192–201. https://doi.org/10.1016/j.msard.2015.03.004 PMid:26008936
Klaren, R. E., Emerson, S., Chiu, C. Y., Kinnett Hopkins, D., McAuley, E., & Motl, R.W. (2016). Levels and rates of physical activity in older adults with multiple sclerosis. Aging and Disease, 7(3), 278–284. https://doi.org/10.14336/AD.2015.1025 PMid:27330842; PMCid:PMC4898924
Krokavcova, M., Nagyova, I., Rosenberger, J., Gavelova, M., Middel, B., Gdovinova, Z., & van Dijk, J. P. (2012). Employment status and perceived health status in younger and older people with multiple sclerosis. International Journal of Rehabilitation Research, 35(1), 40–47. https://doi.org/10.1097/MRR.0b013e32834e6520 PMid:22143555
Kurtzke, J. F. (1983). Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology, 33, 1444–1452. https://doi.org/10.1212/WNL.33.11.1444 PMid:6685237
Łabuz Roszak, B., Kubicka Bączyk, K., Pierzchała, K., Horyniecki, M., Machowska Majchrzak, A. ... Wach, J. (2013). Quality of life in multiple sclerosis: Association with clinical features, fatigue and depressive syndrome. Psychiatria Polska, 47(3), 433–441.
Lobentanz, I. S., Asenbaum, S., Vass, K., Sauter, C., Klösch, G., Kollegger, Kollegger, H. ... Zeitlhofer, J. (2004). Factors influencing quality of life in multiple sclerosis patients: Disability, depressive mood, fatique and sleep quality. Acta Neurologica Scandinavica, 110(1), 6–13. https://doi.org/10.1111/j.1600-0404.2004.00257.x PMid:15180801
Lysandropoulos, A. P., & Havrdova, E. (2015). 'Hidden' factors influencing quality of life in patients with multiple sclerosis. European Journal of Neurology, 22(Suppl 2), S28–S33. https://doi.org/10.1111/ene.12801 PMid:26374511
Meyer-Moock, S., Feng, Y. S., Maeurer, M., Dippel, F. W., & Kohlmann, T. (2014). Systematic literature review and validity evaluation of the Expanded Disability Status Scale (EDSS) and the multiple sclerosis Functional Composite (MSFC) in patients with Multiple Sclerosis. BMC Neurology, 14(58), 1–10. https://doi.org/10.1186/1471-2377-14-58 PMid:24666846; PMCid:PMC3986942
Nicol, B., Salou, M., Laplaud, D. A., & Wekerle, H. (2015). The autoimmune concept of multiple sclerosis. La Presse Medicale, 44(4), 103–112. https://doi.org/10.1016/j.lpm.2015.02.009 PMid:25813101
Papuć, E., & Stelmasiak, Z. (2012). Factors predicting quality of life in a group of Polish subjects with multiple sclerosis: Accounting for functional state, socio-demographic and clinical factors. Clinical Neurology and Neurosurgery, 114(4), 341–346. https://doi.org/10.1016/j.clineuro.2011.11.012 PMid:22137087
Piri Çinar, B., & Güven Yorgun, Y. (2018). What we learned from the history of multiple sclerosis measurement: Expanded Disability Status Scale. Archives of Neuropsychiatry, 55(Suppl 1), 69–75. https://doi.org/10.29399/npa.23343 PMid:30692861; PMCid:PMC6278618
Raffel, J., Wakerley, B., & Richard, N. (2016). Multiple sclerosis. Medicine, 44(9), 537–541. https://doi.org/10.1016/j.mpmed.2016.06.005
Rezapour, A., Kia, A. A., Goodarzi, S., Hasoumi, M., Motlagh, S. N., & Vahedi, S. (2017). The impact of disease caracteristics on multiple sclerosis patients' quality of life. Epidemiology and Health, 39, Article e2017008. https://doi.org/10.4178/epih.e2017008 PMid:28231687; PMCid:PMC5434226
Štern, B., Hojs-Fabjan, T., Rener-Sitar, K., & Zaletel-Kragelj, L. (2017). Validation of the Slovenian version of Multiple Sclerosis Quality of Life (MSQOL-54) instrument. Zdravstveno varstvo, 56(4), 260–267. https://doi.org/10.1515/sjph-2017-0035 PMid:29062401; PMCid:PMC5639816
Udovčić-Pertot, A., Zupanc-Starič, Z., Rotar, E., Drljepan, M., & Kragelj, V. (2016). Ocenjevanje funkcioniranja oseb z multiplo sklerozo v različnih fazah bolezni. Rehabilitacija, 15(Suppl 1), 164–169.
University of California, Los Angeles, Department of Neurology (1995, January 10). Multiple Sclerosis Quality of Life (MSQOL)-54 Instrument. Los Angeles: University of California, 1–16. Retrieved from https://www.nationalmssociety.org/NationalMSSociety/media/MSNationalFiles/Brochures/MSQOL54_995.pdf
Vickrey, B. G., Hays, R. D., Harooni, R., Myers, L. W., & Ellison, G. W. (1995). A health-related quality of life measure for multiple sclerosis. Quality of Life Research 4, 187–206. https://doi.org/10.1007/BF02260859 PMid:7613530
Yamout, B., Zeinab, I., Aline, H., Bejjani, E. M., Khalifa, A., & Ghadieh, A. S. (2013). Predictors of quality of life among multiple sclerosis patients: A comprehensive analysis. European Journal of Neurology, 20(5), 756–764. https://doi.org/10.1111/ene.12046 PMid:23294397
Prenosi
Objavljeno
Kako citirati
Številka
Rubrike
Licenca
Na Obzornik zdravstvene nege, Ob železnici 30A, 1000 Ljubljana, prenašam naslednje materialne avtorske pravice: pravico reproduciranja v neomejeni količini, in sicer v vseh poznanih oblikah reproduciranja, kar obsega tudi pravico shranitve in reproduciranja v kakršnikoli elektronski obliki (23. čl. Zakona o avtorski in sorodnih pravicah – v nadaljevanju ZASP); pravico distribuiranja (24. čl. ZASP); pravico dajanja na voljo javnosti vključno z dajanjem na voljo javnosti prek svetovnega spleta oz. računalniške mreže (32.a čl. ZASP); pravico predelave, zlasti za namen prevoda (33. čl. ZASP). Prenos pravic velja za članek v celoti (vključno s slikami, razpredelnicami in morebitnimi prilogami). Prenos je izključen ter prostorsko in časovno neomejen.
